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Many human fetuses have to adapt to a limited supply of nutrients. In doing so they permanently
change their structure and metabolism. These programmed changes may be the origins of a
number of diseases in later life, including coronary heart disease, hypertension and noninsulin-
dependent diabetes. We review epidemiologic studies in which the incidence of these diseases has
been related to the recorded, early growth of individuals, while considering factors in the adult
lifestyle, such as obesity and socioeconomic status. We discuss possible mechanisms. For
hypertension these mechanisms include placentation, maternal blood pressure, fetal undernutrition;
childhood growth, activation of the renin-angiotensin system, renal structure, programming of the
hypothalamic-pituitary-adrenal axis, vascular structure, and sympathetic nervous activity. For
noninsulin-dependent diabetes we discuss mechanisms concerning both insulin resistance and
insulin deficiency. We include a review of evidence for the programming of serum cholesterol and
clotting factor concentrations. We address the timing of critical windows for coronary heart disease,
reviewing studies that allow assessment of the relative importance of fetal, infant, and childhood
growth. We argue for a research strategy that combines clinical, animal, and epidemiological
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Introduction to Programming
In fetal life the tissues and organs ofthe body
go through what are called critical periods of
development (1). These critical periods may
coincide with periods of rapid cell division.
Programming describes the process whereby a
stimulus or insult at a critical period ofdevel-
opment has lasting or lifelong effects (2,3).
The development of the sweat glands is an
interesting example of this process (4). In
Japan in the early years of this century, mili-
tary expansion took Japanese soldiers and set-
tlers into unfamiliar climates. There were wide
differences in people's abilities to adapt to hot
climates. Physiological studies showed this was
related to the number of functioning sweat
glands. People with more functioning sweat
glands cooled down faster. Rather than
attributing the differences in sweat gland
numbers to genetic effects, Japanese physiolo-
gists explored the early development of the
glands. They found that at birth all humans
have similar numbers of sweat glands, but
none of them function. In the first 3 years
after birth, a proportion ofthe glands become
functional, depending on the temperature to
which the child is exposed. The hotter the
conditions the greater the number of sweat
glands that are programmed to function. After
3 years the programming is complete and the
number of sweat glands is fixed. The develop-
ment of sweat glands encapsulates the essence
of programming-a critical period when the
system is plastic and sensitive to the environ-
ment, followed by loss ofplasticity and a fixed
functional capacity.
Programming ofan
Undernourished Fetus
Undernutrition is one ofthe influences that
program the human body and has lifelong
consequences. Rickets demonstrates that
undernutrition at a critical stage ofearly life
leads to persisting changes in structure. What
is new is the recent realization that some of
the body's memories ofearly undernutrition
become translated into pathology and thereby
determine disease in later life (5). However,
this is unsurprising given animal experiments
that show that undernutrition in utero leads
to persisting changes in blood pressure, cho-
lesterol metabolism, insulin response to glu-
cose, and a range of other metabolic,
endocrine, and immune functions known to
be important in human disease (2,6).
The human fetus adapts to undernutri-
tion by metabolic changes, redistribution of
blood flow, and changes in the production of
fetal and placental hormones that control
growth (7).
Metabolic changes. The immediate meta-
bolic response of the fetus to undernutrition
is catabolism: it consumes its own substrates
to provide energy (8). More prolonged
undernutrition leads to a slowing in growth.
This enhances the ability of the fetus to sur-
vive by reducing the use of substrates and
lowering the metabolic rate. Slowing of
growth in late gestation leads to dispropor-
tion in organ size, since organs and tissues
growing rapidly at the time are affected the
most. Undernutrition in late gestation may,
for example, lead to reduced growth of the
kidney, which is developing rapidly at that
time. Reduced replication ofkidney cells may
permanently reduce cell numbers, because
after birth there seems to be no capacity for
renal cell division to catch-up (9,10).
Redistribution ofbloodflow. While slowing
its rate ofgrowth, the fetus may protect tis-
sues that are important for immediate sur-
vival, especially the brain. One way in which
the brain can be protected is by redistribution
ofblood flow to favor it (11,12). This adapta-
tion occurs in many mammals. In humans it
has exaggerated costs for tissues other than
the brain, notably the liver and other abdomi-
nal viscera, because of the large size of the
human brain.
Endocrine changes. Nutrition has profound
effects on fetal hormones and on the hor-
monal and metabolic interactions between
the fetus, placenta, and mother on whose
coordination fetal growth depends (8). Fetal
insulin and the insulin-like growth factors
(IGF) are thought to have a central role in
the regulation ofgrowth and respond rapidly
to changes in fetal nutrition (13). Ifa mother
decreases her food intake, fetal insulin, IGF,
and glucose concentrations fall, possibly
through the effect of decreased maternal
IGF. This leads to reduction in transfer of
amino acids and glucose from mother to
fetus and ultimately to lower fetal growth
rates (14). In late gestation and after birth,
the growth hormone and IGF axis of the
fetus take over a central role from insulin in
driving linear growth. Whereas undernutri-
tion leads to a fall in the concentrations of
hormones that control fetal growth, it leads
to a rise in cortisol, whose main effects are on
cell differentiation (7).
Programming of Coronary
Heart Disease
The suggestion that coronary heart disease
might originate during fetal development
came from showing the similarity ofthe geo-
graphic pattern ofdeath rates among babies
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in Britain during the early 1900s (15) and the
pattern oftoday's death rates from coronary
heart disease. The usual certified cause of
death in newborn babies at that time was low
birth weight. The suggestion that events in
childhood influence the pathogenesis ofcoro-
nary heart disease was not new. A focus on
intrauterine life, however, offered a new
opportunity for research.
Early epidemiological studies that pointed
to the possible importance ofprogramming
in coronary heart disease were based on the
examination of men and women in middle
and late life whose body measurements at
birth were recorded. Surviving records were
found in Hertfordshire, Preston, and
Sheffield in the United Kingdom. The
Hertfordshire records were maintained by
health visitors and include measurements of
growth in infancy as well as birth weight. In
Preston and Sheffield, detailed obstetric
records documented body proportions at
birth (16,17).
Sixteen thousand men and women born
in Hertfordshire from 1911 to 1930 have
now been traced from birth to the present
day. Death rates from coronary heart disease
fell between those at the lower and upper
ends ofthe birth weight distribution (Table
Table 1. Death rates from coronary heart disease
among 15,726 British men and women according to birth
weight.
Birthweight,
lb(kg)
< 5.5(2.50)
6.5(2.95)
7.5(3.41)
8.5(3.86)
9.5(4.31)
>9.5(4.31)
All
Standardized
mortality ratio
100
81
80
74
55
65
74
No. of deaths
57
137
298
289
103
57
941
Table 2. Standardized mortality ratios for coronary heart
disease in 3,302 Finnish men from 1924 to 1933.
Birth weight, Standardized mortality ratio
kg (Ib) (No. ofdeaths)
<2.5(5.5) 84(11)
3.0(6.6) 83(44)
3.5 (7.7) 99(124)
4.0(8.8) 76(80)
>4.0(8.8) 66(27)
All 85 (286)
pvalue fortrend 0.09
Term babies only
Ponderal index Standardized mortality ratio
at birth(kg/m3) (No. ofdeaths)
<25 116(59)
27 105(88)
29 72(64)
>29 56(33)
All 86 (244)
pvalue fortrend < 0.0001
1) (18). A study in Sheffield showed that it
was people who were small at birth because
they failed to grow, rather than because they
were born early, who were at increased risk of
coronary heart disease (17). The association
between low birth weight and coronary heart
disease has been confirmed in studies of men
in Uppsala, Sweden (19), and Caerphilly,
Wales (20), and amongwomen in the United
States. Among 80,000 women in the
American Nurses Study there was a fall in the
relative risk ofnonfatal coronary heart disease
across the range of birth weights (21). An
association between low birth weight and
prevalent coronary heart disease was also
shown in a study in South India (22). Among
Indian men and women 45 years ofage and
older the prevalence of the disease fell from
18% in those who weighed 5.5 lb at birth to
4% in thosewho weighed 7 lb or more.
The Hertfordshire records and the Nurses
and Caerphilly studies did not include mea-
surements of body size at birth other than
weight. The weight ofa newborn baby, with-
out a measure ofits length, is as crude a sum-
mary of its physique, as is the weight of a
child or adult without a measure of height.
The addition ofbirth length allows a long,
thin baby to be distinguished from a short,
fat baby. With the addition ofhead circum-
ference, the baby whose body is small in rela-
tion to its head as a result of brain-sparing
may also be distinguished. These phenotypes
reflect differing fetal adaptations to undernu-
trition, hypoxia, and other influences and
they have different long-term consequences.
In Sheffield, death rates for coronary
heart disease were higher in men who were
short at birth (23). The mortality ratio for
coronary heart disease in men who were 18.5
in. or less in length was 138 compared with
98 in the remainder. Thinness at birth, as
measured by a low ponderal index (birth
weight/length3), was also associated with
coronary heart disease. Table 2 shows that
although among men born in Helsinki,
Finland, low birth weight was associated
with raised death rates for coronary heart dis-
ease, there was a stronger association with
thinness at birth, especially in men born at
term (24). Men who were thin at birth, as
measured by a low ponderal index, had death
rates that were twice those ofmen who had a
high ponderal index.
In Finland, increased death rates from
coronary heart disease were associated with
low placental weight. In Sheffield, however,
coronary heart disease did not vary with pla-
cental weight but showed a U-shaped rela-
tion with the ratio of placental weight to
birth weight, with the highest mortality
ratios at either end of the distribution. The
pattern ofbody proportions at birth that pre-
dicts death from coronary heart disease
therefore may be summarized as a small head
circumference, shortness or thinness, which
reflect retarded fetal growth, and either low
placental weight or an altered ratio ofplacen-
tal weight to birth weight.
These findings suggest that influences
linked to early fetal and placental growth
have an important effect on the risk ofcoro-
nary heart disease and stroke. It has been
argued, however, that people whose growth
was impaired in uteroand during infancy may
continue to be exposed to an adverse environ-
ment in childhood and adult life, and it is
this later environment that produces the
effects attributed to programming (25-28).
However, in three of the studies that have
replicated the association between birth
weight and coronary heart disease, data on
lifestyle factors including smoking, employ-
ment, alcohol consumption, and exercise
were collected (19-21). Allowance for them
had little effect on the association between
birth weight and coronary heart disease.
In studies exploring the mechanisms
underlying these associations, the trends in
coronary heart disease with birth weight were
found to parallel similar trends in two of its
major risk factors-hypertension and non-
insulin-dependent diabetes mellitus (29,30).
Table 3 illustrates the size of these trends,
with the prevalence of noninsulin-dependent
diabetes mellitus and impaired glucose toler-
ance falling 3-fold between men who weighed
up to 5.5 lb at birth and those who weighed
over 9.5 lb (29). These associations with
small size at birth are again independent of
social class, cigarette smoking, and alcohol
consumption. Influences in adult life, how-
ever, add to the effects of the intrauterine
environment. For example, the prevalence of
Table 3. Prevalence of noninsulin-dependent diabetes and impaired glucose tolerance in men 59-70 years of age.
Odds ratio adjusted
Birth weight, % with impaired glucose for body mass index
lb(kg) No. of men tolerance or diabetes (95% confidence interval)
< 5.5(2.50) 20 40 6.6(1.5-28)
6.5 (2.95) 47 34 4.8 (1.3-17)
7.5(3.41) 104 31 4.6(1.4-16)
8.5(3.86) 117 22 2.6(0.8-8.9)
9.5(4.31) 54 13 1.4(0.3-5.6)
>9.5(4.31) 28 14 1.0
All 370 25
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impaired glucose tolerance is highest in
people who had low birth weight but become
obese as adults.
Programming of Hypertension
Associations between low birth weight and
raised blood pressure in childhood and adult
lifehave been extensivelydemonstrated around
the world. Law and Shiell published a system-
atic reviewofstudies describing the association
between birth weight and blood pressure
(31)-a review based on 34 studies ofmore
than 66,000 people ofall ages in many coun-
tries. In almost all the studies an increase in
birthweight was associated with a fall in blood
pressure, and there was no exception to this in
the studies ofadults, which now total nearly
8,000 men and women. The associations are
less consistent in adolescence, perhaps because
the tracking ofblood pressure from childhood
through adult life is perturbed by the adoles-
cent growth spurt. These associations were not
confounded by socioeconomic conditions at
the time ofbirth or in adult life (32. The dif-
ference in systolic pressure associated with a
kilogram difference in birth weightwas around
3.5 mmHg. In clinical practice thiswould be a
small difference, but there are large differences
between the mean values ofpopulations.
Available data suggest that lowering the mean
systolic pressure in a population by 10 mmHg
would correspond to a 30% reduction in
attributable mortality (33).
The association between low birth weight
and raised blood pressure depends on babies
who were small for dates, after reduced fetal
growth, rather than on babies who were born
preterm (16,34). Although in these studies
alcohol consumption and higher body mass
index were also associated with raised blood
pressure, the associations between birthweight
and blood pressurewereindependent ofthem.
Nevertheless, body mass index remains an
important influence on blood pressure and, in
humans and animals, the highest pressures are
found in people who were small at birth but
become overweight as adults.
As has already been discussed, birth
weight is a crude measure offetal growth that
does not distinguish shortness and thinness,
differences in head size, or variations in the
balance offetal and placental size. In contrast
to the associations between birth size and
coronary heart disease, those between birth
weight and blood pressure are generally as
strong as those between thinness or shortness
and blood pressure (35-38).
PossibleMechanisms
Placentation. Men and women who were
born in Sharoe Green Hospital in Preston 50
years ago had systolic blood pressures that fell
between subjects with low and high birth
weight (16,35), as in other studies. In
addition, however, their blood pressures
increased with increasing placental weight.
Subjects with a mean systolic pressure of 150
mm Hg or more, a level sometimes used to
define hypertension in clinical practice, com-
prise a group who as babies were relatively
small in relation to the size oftheir placentas.
A rise in blood pressure with increasing pla-
cental weight was also found in 4-year-old
children in Salisbury, UK, and among 8-year-
old children in Adelaide, Australia (37,39).
However, in studies ofchildren and adults
the association between placental enlargement
and raised blood pressure has been inconsis-
tent (40). For example, in a study ofmen and
women born in Aberdeen, Scotland, after
World War II, at a time when food was still
rationed, raised blood pressure was associated
with small placental size (41). Animal studies
offer a possible explanation for this inconsis-
tency. In sheep the placenta enlarges in
response to moderate undernutrition in mid-
pregnancy (42,43). This is thought to be an
adaptive response to extract more nutrients
from the mother. It is not, however, a consis-
tent response and occurs only in ewes that
werewell nourished before pregnancy.
Maternal bloodpressure. In some studies
the blood pressures of the mothers during
and after pregnancy have been recorded
(37,44,45). They correlate with the off-
springs' blood pressure. However, the associa-
tions between body size at birth and later
blood pressure are independent ofthe moth-
ers' blood pressures. Recent observations
show that if the mother's blood pressure is
measured throughout a 24-hr period rather
than by isolated readings at antenatal clinics,
there is a continuous inverse association
between birth weight and maternal blood
pressure (46). It could be argued, therefore,
that the association between low birth weight
and raised blood pressure reflects an associa-
tion, possibly genetic, between a mother's
ambulatory blood pressure and the blood
pressure of her offspring. However, the
demonstration that experimental undernutri-
tion during gestation programs blood pres-
sure in animals (47) argues against this
interpretation. An alternative explanation is
that raised blood pressure during pregnancy
reflects failure of maternal cardiovascular
adaptations to pregnancy, which include
peripheral vasodilation, with consequent fetal
undernutrition, low birth weight, and raised
blood pressure in theoffspring.
Fetal undernutrition. Several lines of
evidence support the thesis that it is poor
delivery of nutrients that programs raised
blood pressure in humans. Maternal height,
parity, and cigarette smoking, which influence
fetal growth, have not been found to be
related to the offsprings' blood pressure other
than in small preterm babies (37,48). In
Jamaica children whose mothers had thin
triceps skinfolds in early pregnancy and low
weight gain during pregnancy (49) had raised
blood pressure. There were similar findings in
a group ofchildren in Birmingham, UK (50).
In The Gambia, low pregnancy weight gain
was associated with higher blood pressure in
childhood (51). In Aberdeen, Scotland, the
blood pressures of middle-age men and
women were related to their mothers'
intakes of carbohydrate and protein during
pregnancy (41).
Childhoodgrowth. Studies in the United
States, the United Kingdom, and Holland
have shown that blood pressure in childhood
predicts the likelihood ofdeveloping hyper-
tension in adult life. These predictions are
strongest after adolescence. In children the
rise of blood pressure with age is closely
related to growth and is accelerated by the
adolescent growth spurt. These observations
have led Lever and Harrap to propose that
essential hypertension is a disorder ofgrowth
(52). The hypothesis that hypertension is a
disorder ofaccelerated childhood growth can
be reconciled with the association with low
birth weight by postulating that postnatal
catch-up growth plays an important role in
amplifyingchanges established in utero.
Renin-angiotensin system. There is evidence
that the fetal renin-angiotensin system is acti-
vated during intrauterine growth retardation
(53). However, in a follow-up study ofmen
and women born in Sheffield, those who had
been small at birth had lower plasma concen-
trations of inactive and active renin (54).
Causes ofraised blood pressure that are not
mediated by increased rates of renin release
tend to result in low concentrations ofrenin,
and therefore, at first sight, these findings sug-
gest that the association between impaired fetal
growth and raised blood pressure must involve
mechanisms other than the renin-angiotensin
system. However, low concentrations ofrenin
in adult life do not exclude the possibility that
the renin-angiotensin system has exerted an
earlierbutlastinginfluence.
Renalstture. An alternative explanation
for the low plasma renin concentrations of
people who were small at birth is that they
reflect a relative deficit ofnephrons. Brenner
et al. has suggested that retarded fetal growth
leads to reduced numbers ofnephrons which
in turn leads to increased pressure in the
glomerular capillaries and the development of
glomerular sclerosis (55,56). This sclerosis
leads to further loss ofnephrons and a self-
perpetuating cycle ofhypertension and pro-
gressive glomerular injury. The numbers of
nephrons in the normal population varies
widely, from 300,000 to 1,100,000 or more
(55). Animal and human studies have shown
that low rates ofintrauterine growth are asso-
ciated with reduced numbers ofnephrons
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(57). Studies using fetal ultrasound have
shown that babies who are small for gesta-
tional age have reduced renal growth during
the critical period at 26-34 weeks ofgesta-
tion. This reduces the anteroposterior size of
the kidney but does not diminish kidney
length (58). It has been suggested that during
normal childhood development, kidney
growth lags behind the increases in body
weight, and blood pressure rises to maintain
renal homeostasis (59).
Endocrine. Animal studies have led to the
hypothesis that fetal undernutrition leads to
life-long changes in the hypothalamic-
pituitary-adrenal axis ofthe fetus, which in
turn resets homeostatic mechanisms control-
ling blood pressure (60,61). A recent study of
9-year-old children in Salisbury, UK, showed
that those who had been small at birth had
increased urinary adrenal androgen and glu-
cocorticoid metabolite excretion (62), prelim-
inary evidence that the hypothalamic-
pituitary-adrenal axis is programmed in
humans. The growth hormone insulin-like
growth factor 1 (IGF-1) axis may also be pro-
grammed in utero. Children of low birth
weight have raised plasma IGF-1 concentra-
tions (48,63). The highest concentrations are
in children who had the lowest birth weights
but attain the largest body size in childhood.
Raised IGF-1 concentrations may therefore
be linked to catch-up growth. IGF-1 is
known to be important for the growth of
blood vessels (64), and raised concentrations
could be one ofthe processes underlying the
suggested association between catch-up
growth and raised blood pressure in laterlife.
Vascular structure. The elastic recoil of
the aorta is important in maintaining blood
flow in the peripheral circulation and in the
coronary arteries during diastole. Reduced
elasticity (compliance) in the aorta is a
marker ofcardiovascular disease (65). It is
associated with hypertension, and also with
left ventricular hypertrophy because the work
ofthe left ventricle is increased (66,67). Men
and women 50 years ofage in Sheffield who
were small at birth had reduced compliance
in the large arteries ofthe trunk and legs (44).
Martyn and Greenwald have proposed that
impaired synthesis ofthe scleroprotein elastin
is one ofthe mechanisms underlying the asso-
ciation between low birth weight and raised
blood pressure (68). The elasticity oflarger
arteries largely depends on elastin (69), which
is laid down in utero and during infancy and
thereafter turns over slowly (69). Its half-life
in humans is approximately 40 years (70).
Reduced elastin deposition leads to less com-
pliant, stiffer arteries, which will lead to raised
blood pressure. The loss ofelastin with aging
willamplifythe increase in blood pressure.
In the growth-retarded fetus there are
changes in blood flow in several vascular
beds, including the descending aorta and
cerebral vasculature (71). These are brain-
sparing adaptations that lead to preferential
perfusion ofthe brain at the expense of the
trunk (11,12,72). Ifsustained they may lead
to reduced growth ofthe abdominal viscera
and stunting at birth. Because elastin deposi-
tion in a blood vessel in utero is related to the
flow ofblood, reduced flow in the large arter-
ies ofthe trunk and legs as a consequence of
brain-sparing may be associated with reduced
elastin deposition, less compliant arteries, and
consequent hypertension. Diversion ofoxy-
genated blood away from the trunk to sustain
the growth ofthe brain increases peripheral
resistance (71,73), and echocardiography has
shown that growth-retarded fetuses have
hypertrophy of both ventricles (74,75).
Cardiac myocytes become terminally differ-
entiated before birth and the load on the
heart influences their rate of maturation.
Earlypressure loadingleads to fewer but larger
myocytes. Left ventricular enlargement is
known to be a strong predictor ofmorbidity
and death from coronary heart disease inde-
pendent ofits association with raised systolic
blood pressure and increased body mass (76).
Among 67-year-old men in Hertfordshire
thosewho had had lowweight at 1 year ofage
had concentric enlargement ofthe left ventri-
cle (77). This may reflect the long-term
effects of prenatal blood diversion to the
brain in a baby who is stunted at birth and
whose growth does not catch up in infancy.
An association between low weight around
the age of 1 year and later concentric left ven-
tricular hypertrophy has also been found in a
sample ofchildren and adults in Lorraine,
France (78).
Recent studies suggest that low birth
weight is associated with persisting alterations
in vascular structure and function in addition
to its associations with compliance. Among
men in Hertfordshire, thosewho had had low
birth weight had narrow bifurcation angles in
their retinal blood vessels (79). People with
hypertension have similar changes in retinal
vascular geometry. In a study ofchildren in
the United Kingdom, those who had low
birth weight had reduced flow-mediated
dilatation in the brachial artery after the
artery had been occluded and released. Flow-
mediated dilatation depends on the endothe-
lium. These findings suggest, therefore, a link
between low birth weight and endothelial
dysfunction (80).
Nervous system. People with high blood
pressure tend to have a high resting pulse rate
(81). This is associated with high cardiac out-
put, hyperdynamic circulation, and features of
increased sympathetic nervous system activity
(82). Among men and women in Preston,
those who had low birth weight had a higher
resting pulse rate (83). This is consistent with
the hypothesis that increased sympathetic
nervous activity is established through
retarded growth in utero and leads to raised
blood pressure in later life.
Programming of Noninsulin-
Dependent Diabetes
Insulin has a central role in fetal growth, and
disorders ofglucose and insulin metabolism
are therefore an obvious possible linkbetween
early growth and cardiovascular disease (13).
Although obesity and a sedentary lifestyle are
important in the development ofnoninsulin-
dependent diabetes, they seem to lead to the
disease only in predisposed individuals.
Family and twin studies have suggested famil-
ial predisposition, but the nature ofthis pre-
disposition is unknown. The disease tends to
be transmitted through the maternal rather
than paternal side ofthe family (84).
Size atBirthandNoninsulin-
DependentDiabetes
A number ofother studies have confirmed the
association between birth weight, impaired
glucose tolerance, and noninsulin-dependent
diabetes that was first reported in
Hertfordshire (18,29,85-88) (Table 3). In the
Health Professionals Study in the United
States, the odds ratio for diabetes, after adjust-
ing for current body mass, was 1.9 among
men whose birthweights were less than 5.5 lb
compared with those who weighed 7-8.5 lb
(89). Among the Pima Indians in the United
States, the odds ratio for diabetes was 3.8 in
men andwomenwhoweighed less than 5.5 lb
(90). In Preston it was the thin babies who
developed impaired glucose tolerance and dia-
betes. Lithell and colleagues confirmed the
association with thinness in Uppsala, Sweden
(87) (Table 4). The prevalence ofdiabetes was
3 times higher among men in the lowest fifth
ofponderal index at birth. Thiswas astronger
association than that with birth weight, with
the prevalence ofdiabetes only twice as high
among men in the lowestfifthofbirthweight.
Among the Pima Indians, in whom diabetes
in pregnancy is unusually common, young
men and women with birth weights over 9.9
lb had an increased prevalence ofnoninsulin-
dependent diabetes (90). The association
Table 4. Prevalence of noninsulin-dependent diabetes
by ponderal index at birth among men 60 years of age in
Uppsala, Sweden.
Ponderal index Prevalence of
at birth(kg/m3) Numberof men diabetes(%)
<24.2 193 11.9
24.2 193 5.2
25.9 196 3.6
27.4 188 4.3
>29.4 201 3.5
All 971 5.7
pvalue fortrend 0.001
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between birth weight and noninsulin-
dependent diabetes was therefore U-shaped.
The increased risk ofdiabetes among babies
with high birth weights was associated with
maternal diabetes in pregnancy.
Insulin Resisance
Both deficiency in insulin production and
insulin resistance are thought to be important
in the pathogenesis ofnoninsulin-dependent
diabetes (91). There is evidence that both
may be determined in fetal life. Men and
women with low birth weight have a high
prevalence ofthe insulin resistance syndrome
(92) in which impaired glucose tolerance,
hypertension, and raised serum triglyceride
concentrations occur in the same patient. The
patients are insulin resistant and have hyper-
insulinaemia. Table 5 shows results for asam-
ple ofthe men in Hertfordshire. Phillips et al.
(93) carried out insulin tolerance tests on 103
men and women in Preston. At any value of
adult body mass index, insulin resistance was
greater in people who had a low ponderal
index at birth. In addition, at each ponderal
index, resistance was greater in those with
high body mass index. The greatest mean
resistance was therefore in those with low
ponderal index at birth but high body mass
index as adults.
Arecentstudyin SanAntonio, Texas, con-
firmed the association between low birth
weight and insulin resistance in adifferent eth-
nic group. In 30-year-old Mexican Americans
and non-Hispanic white people, those with
lower birth weight had a higher prevalence of
the insulin resistance syndrome (94). Among
men and women in the lowest third ofthe
birth weight distribution and the highest third
ofcurrent body mass index, 25% had the syn-
drome. In contrast, none ofthe people in the
highest third ofbirth weight and lowest third
ofcurrent body mass index had the syndrome.
In a study ofyoung adults in the city of
Haguenau, France, those who had had
intrauterine growth retardation had raised
plasma insulin concentrations when fasting
and after a standard glucose challenge (95).
Theydid notshowanyofthe otherabnormal-
ities that occur in the insulin resistance syn-
drome. An interpretation ofthis is that insulin
resistance is a primary abnormality to which
other changes are secondary. A recent study of
men andwomen who were in uteroduring the
Dutch famine provides direct evidence that
fetal undernutrition can program insulin resis-
tance and noninsulin-dependent diabetes (96).
Men and women exposed to famine in utero
had higher 2-hr plasma glucose concentrations
than those born before orthoseconceivedafter
the famine. They also had higher fasting pro-
insulin and 2-hr plasma insulin concentra-
tions, suggestinginsulin resistance.
Law et al. reported associations between
thinness at birth and raised 30-minute plasma
glucose concentrations in 7-year old children
in Salisbury, UK (97). Whincup et al. studied
British children 10-11 years ofage and found
that those who had lower birth weight had
raised plasma insulin concentrations both
fasting and after oral glucose (98). This is
consistent with the association between low
birth weight and insulin resistance. Among
these children, however, the plasma glucose
concentrations ofthose who had low birth
weight were unaltered, which implies that
despite being insulin resistant they were able
to maintain glucose homeostasis. In contrast
Yajnik and colleagues found that Indian chil-
dren 4 years ofagewho had lowbirthweights
had raised plasmaglucose and insulin concen-
trations, suggesting that at the levels ofpoor
fetal growth and insulin resistance that prevail
in India, even young children are unable to
maintain glucose homeostasis (99). Forrester
and colleagues found an association between
shortness at birth and reduced glucose toler-
ance among children in Jamaica, in whom
the serum glycated hemoglobin levels rose
progressively between those who were 52 cm
or more in length at birth and those who
were 46 cm or less (100). These findings in
children provide further support for the
hypothesis that noninsulin-dependent dia-
betes originates from impaired development
in utero and that the seeds ofdiabetes in the
next generation have already been sown and
areapparent in today's children.
Mechanisms
The processes that link thinness at birth with
insulin resistance in adult life are not known.
Babies born at termwith alowponderal index
have areduced mid-arm circumference, which
Table 5. Prevalence ofthe insulin resistance syndrome in men 59-70 years ofageaccording to birthweight.
Odds ratio adjusted
Birthweight, % with insulin forbody mass index
lb(kg) No. of men resistance syndrome (95% confidence interval)
<5.5(2.50) 20 30 18(2.6-118)
6.5(2.95) 54 19 8.4(1.5-49)
7.5(3.41) 114 17 8.5(1.5-46)
8.5(3.86) 123 12 4.9(0.9-27)
9.5(4.31) 64 6 2.2(0.3-14)
> 9.5(4.31) 32 6 1.0
All 407 14
implies that they have a low muscle bulk as
well as less subcutaneous fat (101). It is
therefore possible that thinness at birth is
associated with abnormalities in the structure
and function of muscle that develop in
midgestation and persist into adult life, inter-
fering with insulin's ability to promote glu-
cose uptake. Magnetic resonance spectroscopy
studies show that people who were thin at
birth have lower rates ofglycolysis and gly-
colytic adenosine triphosphate production
duringexercise (102). In response to undernu-
trition afetus mayreduce its metabolic depen-
dence on glucose and increase oxidation of
other substrates, including amino acids and
lactate. This has led to the hypothesis that a
glucose-sparing metabolism persists into adult
life, and that insulin resistance arises as a con-
sequence ofsimilar processes, possibly because
of reduced rates of glucose oxidation in
insulin-sensitive peripheral tissues.
When the availability ofnutrients to the
fetus is restricted, concentrations ofanabolic
hormones including insulin and IGF-I fall,
while catabolic hormones, including gluco-
corticoids rise. Persisting hormonal changes
could underlie the development ofinsulin
resistance. Bjorntorp has postulated that glu-
cocorticoids, growth hormone, and sex
steroids mayplayamajor role in the evolution
ofthe metabolicsyndrome (103).
Recent advances in assay methodology
make it possible to specifically measure
plasma concentrations ofthe precursor of
insulin, 32-33-split proinsulin (104,105).
Higher concentrations are found in people
who had low birth weight and low weight at
1 year (29). The significance ofraised plasma
split proinsulin concentrations remains
unclear, but they are thought to indicate both
insulin resistance and pancreatic P-cell
dysfunction.
InsulinDeficiency
Infants who are small for dates have fewer
,Bcells (106). There are conflicting reports on
whether theP-cell mass is reduced in subjects
with noninsulin-dependent diabetes (107). As
a working hypothesis it seems reasonable to
propose that nutritional and other factors
determining fetal and infant growth influence
the size and function ofthe adult pancreatic
P-cell complement. Whether and when non-
insulin dependent diabetes supervenes will be
determined by the rate ofattrition of D cells
with aging, and by the development of
insulin resistance, ofwhich obesity is an
importantdeterminant (108).
In a sample of 103 of the men and
women who participated in the Preston
study, Phillips and colleagues (109) mea-
sured insulin secretion following intravenous
infusion of glucose. The insulin response
was not related to birth weight or other
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measurements at birth. This argues against a
link between reduced fetal growth and
insulin deficiency in adult life. Similarly, a
study ofmen in Stockholm found no associ-
ation between birth weight and insulin
responses to infused glucose (110). Birth
length and other measures ofbirth size were
not available in that study. There was, how-
ever, an association between short stature
and a low insulin response. It is possible that
insulin resistance in adult life changes
insulin secretion and obscures associations
with fetal growth. Studies ofyounger people
may resolve this; a study by Robinson and
colleagues (111) of men 21 years of age
showed that those with lower birth weight
had reduced plasma insulin concentrations
at 30 min. Another study of men ofsimilar
age showed that a low insulin response to
glucose was associated with a high placental
weight and a high ratio ofplacental weight
to birth weight. This study also confirmed
the association between low insulin secretion
and short stature (112). In contrast a study
ofyoung Pima Indians showed that those
with low birth weight had evidence of
insulin resistance but no defect in insulin
secretion (113).
In Mysore, South India, men and women
with noninsulin-dependent diabetes showed
signs of both insulin resistance and insulin
deficiency (114). A high prevalence ofinsulin
resistance, central obesity, and noninsulin-
dependent diabetes in people from South
India living in Britain has been observed
(115,116). The study ofmen and women in
Mysore again showed this. Those who had
noninsulin-dependent diabetes also had a low
insulin increment after a standard challenge,
indicating that they were insulin deficient as
well as resistant. However, whereas insulin
resistance was associated with low birth
weight, noninsulin-dependent diabetes was
associated with shortness at birth in relation
to birth weight (i.e., a high ponderal index)
andwith maternal adiposity.
These findings led to a novel explanation
for the epidemic ofnoninsulin-dependent
diabetes in urban and migrant Indian popula-
tions (114). Widespread fetal undernutrition
predisposes the Indian population to insulin
resistance. When these people move to cities,
their levels ofphysical activity diminish.
Youngwomen, no longer required to do agri-
cultural work or walk long distances to fetch
water and firewood, become fatter and more
insulin resistant. They are therefore unable to
maintain glucose homeostasis during preg-
nancy, even at relatively low levels ofobesity,
and become hyperglycemic, though not nec-
essarily diabetic. It is known that high plasma
glucose concentrations within the normal
range influence fetal growth and lead to
macrosomia (117).
Programming of Serum
Cholesterol and Clotting
Factor Concentrations
Studies in Sheffield, UK, show that the
neonate who has a short body and low birth
weight in relation to the size of its head,
although within the normal range of birth
weight, has persisting disturbances ofcholes-
terol metabolism and blood coagulation
(118-120). Disproportion in body length rel-
ative to head size is thought to result from
undernutrition in late gestation. The fetus
diverts oxygenated blood away from the
trunk to sustain the brain. This affects the
growth ofthe liver, ofwhich two functions,
regulation ofcholesterol and ofblood clot-
ting, seem to be permanently perturbed.
Disturbance ofcholesterol metabolism and
blood clotting are both important features of
coronaryheartdisease.
The Sheffield records included abdominal
circumference at birth as well as length, and it
was reduction specifically in this birth mea-
surement that predicted raised serum low-
density lipoprotein cholesterol and plasma
fibrinogen concentrations in adult life
(118,119). The differences in concentrations
across the range ofabdominal circumference
(Table 6) were large, statistically equivalent to
30% differences in mortality caused by coro-
nary heart disease. The findings for plasma
fibrinogen concentrations, a measure ofblood
coagulability, were ofsimilar size.
Because both cholesterol and fibrinogen
metabolism are regulated by the liver, one
interpretation of these findings is that
reduced abdominal circumference at birth
reflects impaired liver growth and consequent
reprogramming ofliver metabolism. Further
understanding ofliver programming may
come more rapidly from animal studies than
from human studies. Experiments with rats
have shown that undernutrition in utero can
permanently alter the balance of two liver
enzymes, phosphoenol-pyruvate carboxyki-
nase and glucokinase, that are involved in the
synthesis and breakdown ofglucose, respec-
tively (121). A low-protein diet during gesta-
tion permanently changes the balance of
enzyme activity in the offspring in favor of
synthesis. It is thought that this reflects
enhancement ofcell replication in the area
around the portal vein, which carries blood
from the gut to the liver, at the expense of
the cells around the hepatic vein. These
experiments are ofparticular interest because
they show that undernutrition after birth
has no effect and because the two enzymes
are not normally synthesized until after
birth, which suggests that their production
can be regulated before the genes encoding
them are transcribed.
Infant and Childhood Growth
Two studies ofcoronary heart disease and its
risk factors in adult life contain data on both
birth measurements and postnatal growth.
These are the studies in Hertfordshire, UK,
and Helsinki, Finland.
In Hertfordshire, health visitors recorded
the weight of infants when they reached
1 year ofage. In men there have been 853
deaths from coronary heart disease (18). Risk
was more strongly associated with weight at
1 year ofage (x2, = 27.5, p < 0.0001) than
with birth weight (x2i = 8.5, p < 0.005).
Standardized mortality ratios fell progres-
sively from 105 for those who weighed up to
18 lb down to 42 for those who weighed
27 lb or more, a relative riskof2.5. However,
in women, among whom there were only 88
deaths, the closer association was with birth
weight (x21 = 4.3, p = 0.04). Weight at 1 year
ofage is more weakly associated with systolic
blood pressure than is birth weight (122),
equally as associated with glucose tolerance
(29) and serum cholesterol concentrations
(118), and more strongly associated with
plasmaclotting factorconcentrations (119).
In Helsinki the maternity hospital records
have been linked to school records, which
include measurements ofheight and weight
every 6 months between 6 and 16years ofage
(123). Death from coronary heart disease was
associated with low birth weight and more
strongly with a low ponderal index at birth
(Table 2). Men who died from coronary
heart disease had an above-average body mass
index at all ages from 6 to 16 years. In a
simultaneous regression the hazard ratio for
death from the disease increased by 14%
(95% confidence interval 8-19%; p <
0.0001) for each unit (kg/m3) decrease in
ponderal index at birth and by 22%
(10-36%, p = 0.0001) for each unit (kg/m2)
Table 6. Mean serum cholesterol concentrations according to abdominal circumference at birth in men and women
50-53 years of age.
Abdominal circumference, Total cholesterol Low-density lipoprotein
inches (cm) No. of people (mmol/L) cholesterol (mmol/L)
< 11.5(29.2) 53 6.7 4.5
12.0(30.5) 43 6.9 4.6
12.5(31.8) 31 6.8 4.4
13.0(33.0) 45 6.2 4.0
> 13.0 (33.0) 45 6.1 4.0
All 217 6.5 4.3
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increase in body mass index at 11 years of
age. Thus, the highest death rates from coro-
nary heart disease occurred in boys who were
thin at birth but whose weight caught up so
that they had an average or above-average
body mass index from 6 years of age.
However, there was also some evidence ofan
interaction. Figure 1 shows contours ofhaz-
ard ratio for death from coronary heart dis-
ease. Those with a high ponderal index at
birth cross few contour lines by developing a
high body mass index in childhood. In con-
trast those with a low ponderal index at birth
increase their risk more dramatically bydevel-
oping a high body mass index. Conversely, it
is insufficient to know only the body mass
index ofan 11-year-old boy. His future risk
ofdeath from coronary heart disease depends
on his intrauterine growth. To predict the
future, we need to know both the present and
the past.
Catch-up growth could be associated with
adverse outcomes through altered body com-
position in later life. Babies who are thin at
birth lack muscle. It is possible that ifthey
develop ahigh body mass index in childhood,
theyhave adisproportionately high fat mass.
Summary
Associations between low birth weight and
coronary heart disease, raised blood pressure,
and noninsulin-dependent diabetes have been
repeatedly demonstrated. Relatively few
studies have had access to measurements of
birth size other than weight. This is a major
limitation because birth weight is a crude
summary index ofgrowth, and because blood
pressure and glucose/insulin metabolism can
be programmed by nutritional influences that
do not alter birthweight. Studies that indude
birth length suggest that thinness at birth is
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Figure 1. Hazard ratios for death from coronary heart
disease according to ponderal index at birth and body
mass index at 11 years of age. Arrows indicate average
values. Subjects are 3,641 men born at the Helsinki
University Central Hospital from 1924 to 1933.
associated with the development ofinsulin
resistance. Other associations, for example,
those with blood pressure, are less consistent.
One interpretation ofthis is that blood pres-
sure can be programmed at various stages of
gestation, whereas insulin resistance is pro-
grammed in late gestation, when dispropor-
tionate fetal growth is manifest. This is,
however, an uncertain inference and is not
borne out by the Dutch famine study in
which reduced glucose tolerance was associ-
ated with exposure to famine at any stage of
gestation. Associations between placental size
and later disease differ among studies. In ani-
mals placental responses to undernutrition
depend on the mother's nutritional state
before pregnancy, but we have little informa-
tion about this in humans. However, placen-
tal growth and function do seem to be
influences that program the fetus, even when
the placenta is not clinically abnormal.
The Future
Ifwe are to use the information outlined
here, to prevent disease we need to progress
beyond epidemiologic associations to greater
understanding ofthe cellular and molecular
processes that underlie them. We need to
know what factors limit the delivery ofnutri-
ents and oxygen to the human fetus, how the
fetus adapts to a limited supply, how these
adaptations program the structure and physi-
ology of the body, and by what molecular
mechanisms nutrients and hormones alter
gene expression. Further research requires a
strategy ofinterdependent clinical, animal,
and epidemiologic studies.
Asyet, we do not knowthe true impact of
maternal nutrition on fetal development. The
relatively disappointing effects ofnutritional
interventions in pregnancy on fetal growth in
humans have led to the view that fetal devel-
opment is little affected by changes in mater-
nal nutrition except in circumstances of
famine. However, it is clear that birth weight
alone is an inadequate summary measure of
fetal growth; we need a more sophisticated
view ofoptimal fetal development that takes
account ofthe long-term sequelae of fetal
adaptations to undernutrition.
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